Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection
Urologic Oncology: Seminars and Original Investigations Nov 08, 2017
Faiena I, et al. - In this study the survival of patients with metastatic renal cell carcinoma (mRCC) and cN1 disease who underwent cytoreductive nephrectomy (CN) with and without lymph node dissection (LND) was determined. There was no survival benefit among patients with mRCC and cN1 disease undergoing LND when compared with patients undergoing CN; however, when adjusting for the number of positive lymph nodes, lymph node yield indicated an increase in survival.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries